These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 32293456)

  • 21. Paraoxonase1-192 polymorphism modulates the nonfatal myocardial infarction risk associated with decreased HDLs.
    Sentí M; Tomás M; Marrugat J; Elosua R;
    Arterioscler Thromb Vasc Biol; 2001 Mar; 21(3):415-20. PubMed ID: 11231922
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Paraoxonase-1 activities in individuals with different HDL circulating levels: Implication in reverse cholesterol transport and early vascular damage.
    Cervellati C; Vigna GB; Trentini A; Sanz JM; Zimetti F; Dalla Nora E; Morieri ML; Zuliani G; Passaro A
    Atherosclerosis; 2019 Jun; 285():64-70. PubMed ID: 31029939
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of dilution on high-density lipoprotein associated paraoxonase-1 activity.
    Mackness M; Mackness B
    Clin Biochem; 2011 Oct; 44(14-15):1270-1. PubMed ID: 21854764
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Paraoxonase 1 (PON1) enhances HDL-mediated macrophage cholesterol efflux via the ABCA1 transporter in association with increased HDL binding to the cells: a possible role for lysophosphatidylcholine.
    Rosenblat M; Vaya J; Shih D; Aviram M
    Atherosclerosis; 2005 Mar; 179(1):69-77. PubMed ID: 15721011
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HDL function is impaired in acute myocardial infarction independent of plasma HDL cholesterol levels.
    Annema W; Willemsen HM; de Boer JF; Dikkers A; van der Giet M; Nieuwland W; Muller Kobold AC; van Pelt LJ; Slart RH; van der Horst IC; Dullaart RP; Tio RA; Tietge UJ
    J Clin Lipidol; 2016; 10(6):1318-1328. PubMed ID: 27919348
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Age and Cardiovascular Risk Attributable to Apolipoprotein B, Low-Density Lipoprotein Cholesterol or Non-High-Density Lipoprotein Cholesterol.
    Sniderman AD; Islam S; McQueen M; Pencina M; Furberg CD; Thanassoulis G; Yusuf S
    J Am Heart Assoc; 2016 Oct; 5(10):. PubMed ID: 27737874
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HDL (High-Density Lipoprotein) Cholesterol Efflux Capacity Is Associated With Incident Cardiovascular Disease in the General Population.
    Ebtehaj S; Gruppen EG; Bakker SJL; Dullaart RPF; Tietge UJF
    Arterioscler Thromb Vasc Biol; 2019 Sep; 39(9):1874-1883. PubMed ID: 31315436
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High-sensitivity CRP may be a marker of HDL dysfunction and remodeling in patients with acute coronary syndrome.
    Tang X; Mao L; Chen J; Zhang T; Weng S; Guo X; Kuang J; Yu B; Peng D
    Sci Rep; 2021 Jun; 11(1):11444. PubMed ID: 34075063
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High-Density Lipoprotein Particles, Cell-Cholesterol Efflux, and Coronary Heart Disease Risk.
    Asztalos BF; Horvath KV; Schaefer EJ
    Arterioscler Thromb Vasc Biol; 2018 Sep; 38(9):2007-2015. PubMed ID: 30002062
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of cholesteryl ester transfer protein inhibition on lipids, lipoproteins, and markers of HDL function after an acute coronary syndrome: the dal-ACUTE randomized trial.
    Ray KK; Ditmarsch M; Kallend D; Niesor EJ; Suchankova G; Upmanyu R; Anzures-Cabrera J; Lehnert V; Pauly-Evers M; Holme I; Štásek J; van Hessen MW; Jones P;
    Eur Heart J; 2014 Jul; 35(27):1792-800. PubMed ID: 24639426
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum Amyloid A, Paraoxonase-1 Activity, and Apolipoprotein Concentrations as Biomarkers of Subclinical Atherosclerosis Risk in Adrenal Incidentaloma Patients.
    Imga NN; Topcuoglu C; Berker D; Turhan T
    Arch Med Res; 2018 Apr; 49(3):182-190. PubMed ID: 30031631
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Atrial fibrillation is associated with alterations in HDL function, metabolism, and particle number.
    Trieb M; Kornej J; Knuplez E; Hindricks G; Thiele H; Sommer P; Scharnagl H; Dagres N; Dinov B; Bollmann A; Husser D; Marsche G; Buettner P
    Basic Res Cardiol; 2019 May; 114(4):27. PubMed ID: 31069509
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Paraoxonase 1 and platelet-activating factor acetylhydrolase activities in patients with low hdl-cholesterol levels with or without primary hypertriglyceridemia.
    Brites FD; Verona J; Schreier LE; Fruchart JC; Castro GR; Wikinski RL
    Arch Med Res; 2004; 35(3):235-40. PubMed ID: 15163466
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma oxidized high-density lipoprotein and glycated apolipoprotein A-I concentrations in ST-segment elevation myocardial infarction patients with stress hyperglycaemia or high thrombus burden.
    Li BQ; Zhong YC; Wang X
    Ups J Med Sci; 2018 Sep; 123(3):158-166. PubMed ID: 30259778
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Paraoxonase (Pon1) Q192R polymorphism and serum Pon1 activity in diabetic patients on maintenance hemodialysis.
    Zhang B; Eto S; Fan P; Bian C; Shimoji E; Saito T; Saku K
    Clin Nephrol; 2003 Oct; 60(4):257-65. PubMed ID: 14579940
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum myeloperoxidase/paraoxonase 1 ratio as potential indicator of dysfunctional high-density lipoprotein and risk stratification in coronary artery disease.
    Haraguchi Y; Toh R; Hasokawa M; Nakajima H; Honjo T; Otsui K; Mori K; Miyamoto-Sasaki M; Shinohara M; Nishimura K; Ishida T; Hirata K
    Atherosclerosis; 2014 Jun; 234(2):288-94. PubMed ID: 24704632
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Elevated HDL2-paraoxonase and reduced CETP activity are associated with a dramatically lower ratio of LDL-cholesterol/total cholesterol in a hypercholesterolemic and hypertriglyceridemic patient.
    Lee JH; Park JH; Lee SH; Kim JR; Cho KH
    Int J Mol Med; 2010 Jun; 25(6):945-51. PubMed ID: 20428800
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HDL Phospholipids, but Not Cholesterol Distinguish Acute Coronary Syndrome From Stable Coronary Artery Disease.
    Meikle PJ; Formosa MF; Mellett NA; Jayawardana KS; Giles C; Bertovic DA; Jennings GL; Childs W; Reddy M; Carey AL; Baradi A; Nanayakkara S; Wilson AM; Duffy SJ; Kingwell BA
    J Am Heart Assoc; 2019 Jun; 8(11):e011792. PubMed ID: 31131674
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Defective functionality of small, dense HDL3 subpopulations in ST segment elevation myocardial infarction: Relevance of enrichment in lysophosphatidylcholine, phosphatidic acid and serum amyloid A.
    Rached F; Lhomme M; Camont L; Gomes F; Dauteuille C; Robillard P; Santos RD; Lesnik P; Serrano CV; Chapman MJ; Kontush A
    Biochim Biophys Acta; 2015 Sep; 1851(9):1254-61. PubMed ID: 26037829
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Paraoxonase, a cardioprotective enzyme: continuing issues.
    Getz GS; Reardon CA
    Curr Opin Lipidol; 2004 Jun; 15(3):261-7. PubMed ID: 15166781
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.